Diagnostics-as-a-Service Market Report 2025

The diagnostics-as-a-service market size has grown exponentially in recent years. It will grow from $4.45 billion in 2024 to $5.4 billion in 2025 at a compound annual growth rate (CAGR) of 21.2%. The growth in the historic period can be linked to the rise of digital healthcare, increasing demand for early disease detection, wider adoption of cloud-based solutions, growing healthcare costs driving the need for efficient approaches, and a heightened demand for faster, more accurate diagnostics.

The diagnostics-as-a-service market size is expected to see exponential growth in the next few years. It will grow to $11.5 billion in 2029 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be linked to the rising prevalence of chronic diseases, expansion of personalized medicine, growing demand for remote and home-based testing, increased focus on cost-effective diagnostics, and supportive regulatory measures for digital healthcare solutions. Key trends during the forecast period include the use of AI-driven diagnostics, adoption of cloud-based platforms, integrated multi-omics approaches, remote and at-home testing, real-time analytics with digital reporting, blockchain-enabled data security, and patient-centric, personalized diagnostic services.

The rising prevalence of chronic diseases is expected to drive the expansion of the diagnostics-as-a-service market in the coming years. Chronic diseases are long-lasting health conditions that require ongoing medical care, often becoming more prevalent due to inactive lifestyles. Sedentary behavior, such as prolonged sitting and minimal physical activity, increases the likelihood of developing conditions such as heart disease and diabetes. Diagnostics-as-a-service plays a crucial role in managing chronic diseases by enabling cloud-based testing and analysis, which facilitates the monitoring of long-term health conditions. This service enhances patient care by providing timely insights, reducing the need for frequent hospital visits, and improving accessibility for individuals with chronic health concerns. For example, in June 2024, the National Health Service in the UK reported that 3,615,330 individuals were diagnosed with non-diabetic hyperglycemia, a condition indicating elevated blood sugar levels, in 2023, an 18% increase from 2022. This trend highlights the growing demand for continuous monitoring, driving the diagnostics-as-a-service market.

The increasing adoption of personalized medicine is also contributing to the growth of the diagnostics-as-a-service market. Personalized medicine tailors treatment and prevention plans based on an individual's genetic makeup, lifestyle, and environment. The rise of this approach is largely due to advancements in genomics, which allow for the precise identification of genetic variations and the creation of individualized treatments. Diagnostics-as-a-service enhances personalized medicine by offering cloud-based diagnostic tools that provide rapid, accurate patient assessments. These services streamline data collection and analysis, supporting customized treatment strategies and improving clinical decision-making. For instance, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. This surge in personalized medicine adoption is fueling the growth of the diagnostics-as-a-service market.

Companies in the diagnostics-as-a-service market are increasingly focusing on developing patient-centric solutions, such as at-home lab testing services, to improve convenience and accessibility. At-home lab testing services allow individuals to collect samples at home and receive test results without needing to visit a clinic. For example, in June 2025, Amazon India partnered with Orange Health Labs to launch Amazon Diagnostics, an at-home lab testing service under Amazon Medical. Available in six major cities, the service offers doorstep sample collection within 60 minutes and delivers digital reports in as little as six hours, covering over 800 diagnostic tests. Customers can book, track, and access secure test results through the Amazon app. This initiative addresses key challenges in India's diagnostic sector, such as delays, accessibility, and quality, while aligning with Amazon's broader goal of providing comprehensive healthcare services, including pharmacy and clinics.

Major players in the diagnostics-as-a-service market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., Invitae Corporation, InHealth Group Limited, Canon Medical Systems Corporation, Freenome Holdings Inc., BioSerenity SAS, PathAI Inc., Butterfly Network Inc., Aidoc Medical Ltd., Owkin Inc., K Health Inc., and Probatix GmbH.

North America was the largest region in the diagnostics-as-a-service market in 2024. The regions covered in diagnostics-as-a-service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the diagnostics-as-a-service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Diagnostics-as-a-service is a cloud-based healthcare approach that offers diagnostic testing, analysis, and reporting via digital platforms, often utilizing artificial intelligence (AI), internet of things (IoT), and remote connectivity. It provides scalable, cost-efficient, and accessible diagnostic solutions without requiring extensive on-site infrastructure. The model supports real-time health monitoring, quicker decision-making, and better patient outcomes by optimizing diagnostic delivery across healthcare environments.

The primary elements of diagnostics-as-a-service are software, services, and hardware. Software includes cloud-based platforms that deliver on-demand diagnostic testing, analysis, and reporting, facilitating scalable, cost-effective, and accessible healthcare diagnostics. It can be implemented through cloud-based, on-premises, or hybrid systems. Applications cover clinical diagnostics, imaging, pathology, genomics, and more, serving hospitals, clinics, diagnostic laboratories, research institutes, and other users.

The diagnostics-as-a-service market research report is one of a series of new reports that provides diagnostics-as-a-service market statistics, including the diagnostics-as-a-service industry global market size, regional shares, competitors with the diagnostics-as-a-service market share, detailed diagnostics-as-a-service market segments, market trends, and opportunities, and any further data you may need to thrive in the diagnostics-as-a-service industry. This diagnostics-as-a-service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diagnostics-as-a-service market includes revenues earned by entities through remote diagnostic testing, laboratory analysis, sample collection and processing, cloud-based reporting, and teleconsultation for test interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.